Robo-advisory: Assessing the Threat, and How Banks Should Respond in a Time of Increased Transparency Requirements

Tax overhaul creates strategic decision point for US life science companies The House and Senate tax overhaul proposals outline changes that will impact every sector of US business, and the life science industry is no exception. With a large reduction in corporate tax rate, the legislative proposals would free up significant cash flow for US pharma and biotech companies of all sizes. We